Summary

Market Overview:

The global cancer vaccines market size reached US$ 6.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 12.1 Billion by 2028, exhibiting a growth rate (CAGR) of 11.61% during 2023-2028.

Cancer is a malignant tumor caused by the uncontrollable growth of abnormal cells in the body. It can be treated through the use of various medications and vaccines. Between these, vaccines are broadly categorized into preventive and therapeutic. Preventive cancer vaccines are deployed for eliminating cancer caused by oncovirus and protecting from human papillomavirus (HPV), whereas therapeutic vaccines aid in stimulating the individual adaptive immune systems by using tumor antigens. At present, cancer vaccines are commercially available in varying types, such as antigen, dendritic cell, and anti-idiotype.

Cancer Vaccines Market Trends:
The increasing prevalence of cancer, especially due to the rising consumption of tobacco-based products and evolving lifestyles is currently driving the cancer vaccines market growth. In line with this, favorable initiatives undertaken by the government bodies of several nations for introducing novel cancer vaccines, along with extensive fundings in the field of viral recombinant cancer vaccines are further facilitating the widespread adoption of these vaccines in the healthcare sector. In line with this, the extensive utilization of United States Food and Drug Administration (US FDA) approved vaccines, including human papillomavirus vaccine (HPV) and hepatitis B vaccine (HBV) to reduce the risk of certain types of cancer, such as liver cancer, is contributing to the market growth. The market is also significantly driven by rapid technological advancements focusing on the development of effective and specific cancer treatments. Other factors, such as improving healthcare infrastructure, rising geriatric population, who are susceptible to various chronic ailments, including cancer, and growing consumer awareness regarding the symptoms and the available treatment options, are creating a positive outlook for the market further across the globe.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global cancer vaccines market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, technology, indication and end user.

Breakup by Type:

Preventive Cancer Vaccines
Therapeutic Cancer Vaccines

Breakup by Technology:

Dendritic Cells Cancer Vaccines
Recombinant Cancer Vaccines
Antigen/Adjuvant Cancer Vaccines
Viral Vector and DNA Cancer Vaccines
Whole-cell Cancer Vaccines

Breakup by Indication:

Cervical Cancer
Prostate Cancer
Others

Breakup by End User:

Pediatrics
Adults

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Anixa Biosciences Inc., Dendreon Pharmaceuticals LLC, Dynavax Technologies Corporation, GSK plc, Merck & Co. Inc., Moderna Inc., OSE Immunotherapeutics, Providence Therapeutics, Sanofi S.A., UbiVac Inc. and Vaccitech plc.

Key Questions Answered in This Report:
How has the global cancer vaccines market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global cancer vaccines market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the indication?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global cancer vaccines market and who are the key players?
What is the degree of competition in the industry?

ページTOPに戻る

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Cancer Vaccines Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Preventive Cancer Vaccines
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Therapeutic Cancer Vaccines
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Technology
7.1 Dendritic Cells Cancer Vaccines
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Recombinant Cancer Vaccines
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Antigen/Adjuvant Cancer Vaccines
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Viral Vector and DNA Cancer Vaccines
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Whole-cell Cancer Vaccines
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Indication
8.1 Cervical Cancer
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Prostate Cancer
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by End User
9.1 Pediatrics
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Adults
9.2.1 Market Trends
9.2.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Anixa Biosciences Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.2 Dendreon Pharmaceuticals LLC
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Dynavax Technologies Corporation
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.4 GSK plc
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Merck & Co. Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Moderna Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.7 OSE Immunotherapeutics
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.8 Providence Therapeutics
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Sanofi S.A.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 UbiVac Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 Vaccitech plc
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials

List of Figures

Figure 1: Global: Cancer Vaccines Market: Major Drivers and Challenges
Figure 2: Global: Cancer Vaccines Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Cancer Vaccines Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Cancer Vaccines Market: Breakup by Type (in %), 2022
Figure 5: Global: Cancer Vaccines Market: Breakup by Technology (in %), 2022
Figure 6: Global: Cancer Vaccines Market: Breakup by Indication (in %), 2022
Figure 7: Global: Cancer Vaccines Market: Breakup by End User (in %), 2022
Figure 8: Global: Cancer Vaccines Market: Breakup by Region (in %), 2022
Figure 9: Global: Cancer Vaccines (Preventive Cancer Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Cancer Vaccines (Preventive Cancer Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Cancer Vaccines (Therapeutic Cancer Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Cancer Vaccines (Therapeutic Cancer Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Cancer Vaccines (Dendritic Cells Cancer Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Cancer Vaccines (Dendritic Cells Cancer Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Cancer Vaccines (Recombinant Cancer Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Cancer Vaccines (Recombinant Cancer Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Cancer Vaccines (Antigen/Adjuvant Cancer Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Cancer Vaccines (Antigen/Adjuvant Cancer Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Cancer Vaccines (Viral Vector and DNA Cancer Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Cancer Vaccines (Viral Vector and DNA Cancer Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Cancer Vaccines (Whole-cell Cancer Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Cancer Vaccines (Whole-cell Cancer Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Cancer Vaccines (Cervical Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Cancer Vaccines (Cervical Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Cancer Vaccines (Prostate Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Cancer Vaccines (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Cancer Vaccines (Other Indications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Cancer Vaccines (Other Indications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Cancer Vaccines (Pediatrics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Cancer Vaccines (Pediatrics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Cancer Vaccines (Adults) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Cancer Vaccines (Adults) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: North America: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: North America: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: United States: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: United States: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Canada: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Canada: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Asia-Pacific: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Asia-Pacific: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: China: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: China: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Japan: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Japan: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: India: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: India: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: South Korea: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: South Korea: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Australia: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Australia: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Indonesia: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Indonesia: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Others: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Others: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Europe: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Europe: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Germany: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Germany: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: France: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: France: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: United Kingdom: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: United Kingdom: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Italy: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Italy: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Spain: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Spain: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Russia: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Russia: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Others: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Others: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Latin America: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Latin America: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Brazil: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Brazil: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Mexico: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Mexico: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Others: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Others: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Middle East and Africa: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Middle East and Africa: Cancer Vaccines Market: Breakup by Country (in %), 2022
Figure 81: Middle East and Africa: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: Global: Cancer Vaccines Industry: SWOT Analysis
Figure 83: Global: Cancer Vaccines Industry: Value Chain Analysis
Figure 84: Global: Cancer Vaccines Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Cancer Vaccines Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Cancer Vaccines Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Cancer Vaccines Market Forecast: Breakup by Technology (in Million US$), 2023-2028
Table 4: Global: Cancer Vaccines Market Forecast: Breakup by Indication (in Million US$), 2023-2028
Table 5: Global: Cancer Vaccines Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 6: Global: Cancer Vaccines Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Cancer Vaccines Market: Competitive Structure
Table 8: Global: Cancer Vaccines Market: Key Players